[3LBA-115] New therapeutic strategy for acute myeloid leukemia (AML) using lysosomal function.
Gemtuzumab ozogamicin, mTORC1/2 inhibitor, AML, ADC
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.